Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative Multimodal Bowel Perfusion Quantification Combining Hyperspectral Imaging and Indocyanine Green.

Diagnostics (Basel, Switzerland)·2026
Same author

In Vivo Hyperspectral Imaging of Vasogenic Edema and Cortical Oxygenation in Meningiomas: A Subgroup Interim Analysis of a Prospective Study.

Neurosurgery·2026
Same author

Development and application of a structured preclinical protocol for MRI-guided endomyocardial biopsy: a multimodal imaging approach using a hybrid vessel phantom and porcine in vivo models.

Zeitschrift fur medizinische Physik·2026
Same author

Laparoscopic hyperspectral imaging for in vivo detection of the vagal nerve in upper gastrointestinal surgery.

Surgical endoscopy·2025
Same author

Image stitching for real-time laparoscopic hyperspectral imaging.

Scientific reports·2025
Same author

A New Versatile System for 3D Steered LIFU Based on 2D Matrix Arrays.

Brain connectivity·2025

Related Experiment Video

Updated: Jun 8, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Engineered biocompatible nanoparticles for in vivo imaging applications.

Shu Chen1, Lijun Wang, Suzanne L Duce

  • 1School of Physics and Astronomy (SUPA), University of St Andrews, St Andrews KY16 9SS, UK.

Journal of the American Chemical Society
|October 6, 2010
PubMed
Summary

Iron-platinum alloy nanoparticles show potential as advanced magnetic resonance contrast agents for cancer imaging and therapy. These biocompatible nanoparticles exhibit low cytotoxicity and effective cell uptake for in vivo applications.

More Related Videos

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Related Experiment Videos

Last Updated: Jun 8, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Iron-platinum alloy nanoparticles (FePt NPs) possess advantageous properties like high Curie temperature and magnetic moment.
  • Existing contrast agents have limitations, driving the need for novel materials in magnetic resonance (MR) imaging.
  • FePt NPs offer potential for next-generation diagnostic and therapeutic applications in medicine.

Purpose of the Study:

  • To synthesize and characterize biocompatible FePt NPs for biomedical applications.
  • To evaluate the cytotoxicity and cell internalization of FePt NPs.
  • To demonstrate the utility of FePt NPs as contrast agents for cellular and in vivo MR imaging.

Main Methods:

  • Synthesis and characterization of FePt NPs.
  • Biocompatibility and cytotoxicity assessments.
  • Cellular imaging and in vivo MR imaging studies.
  • Interface engineering with coatings for aqueous permeation.

Main Results:

  • Successfully synthesized biocompatible FePt NPs with low cytotoxicity.
  • Demonstrated effective cellular internalization of FePt NPs.
  • Confirmed FePt NPs' capability for cellular imaging and in vivo MR imaging.
  • Highlighted the importance of interface engineering for NP performance.

Conclusions:

  • FePt NPs are promising candidates for advanced MR diagnostic imaging and MR-guided interventions.
  • Engineered FePt NPs can serve as effective diagnostic and therapeutic MRI contrast agents.
  • FePt NPs have potential applications in regenerative medicine and stem cell therapy.